Stepwise renal lineage differentiation of mouse embryonic stem cells tracing in vivo development

Masaki Nishikawa1, Naomi Yanagawa, Nobuhiko Kojima

  • 1Medical and Research Services, Greater Los Angeles Veterans Affairs Healthcare System at Sepulveda, North Hills, CA 91343, USA. masakiwestriver@gmail.com

Insights

Researchers developed a new protocol to generate renal progenitor cells from mouse embryonic stem cells (mESC). This method mimics in vivo development, offering a promising avenue for renal cell therapy and regeneration research.

Area of Science:

  • Stem Cell Biology
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Generating renal lineage progenitor cells in vitro is crucial for advancing renal cell therapy and regeneration.
  • Existing protocols for inducing renal lineages from embryonic stem cells are not yet established.

Purpose of the Study:

  • To establish a protocol for inducing renal lineages from mouse embryonic stem cells (mESC) by mimicking in vivo developmental stages.
  • To identify key signaling pathways and factors for mesoderm, intermediate mesoderm, and renal lineage induction.

Main Methods:

  • Sequential addition of signaling molecules (Activin-A, BMP-4, Lithium) to mimic embryonic development stages.
  • Utilized retinoic acid and conditioned media from ureteric bud (UB) and metanephric mesenchyme (MM) cells for lineage induction.
  • Monitored expression of key developmental markers (Brachyury, Pax2, Lim1, WT1, Cadherin 11) and progenitor cell marker CD24.

Main Results:

  • Successfully induced mesoderm (Stage I) using Activin-A, BMP-4, and Lithium, evidenced by Brachyury expression.
  • Induced nephrogenic intermediate mesodermal markers (Pax2, Lim1) (Stage II) with retinoic acid.
  • Achieved induction of metanephric mesenchyme (MM) and ureteric bud (UB) markers (Stage III) using conditioned media, with CD24 identified as a potential progenitor cell marker.

Conclusions:

  • Stepwise induction mimicking in vivo development effectively generates renal lineage progenitor cells from mESC.
  • CD24 is a potential surface marker for identifying renal lineage cells at Stage II and MM cells at Stage III.
  • This protocol provides a foundation for future renal cell therapy and regenerative strategies.